1067 related articles for article (PubMed ID: 30626681)
1. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
[TBL] [Abstract][Full Text] [Related]
3. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
[TBL] [Abstract][Full Text] [Related]
4. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
Shao J; Huang Q; Liu X; Di D; Dileepan M; Brisse M; Ly H; Liang Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462569
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Gowen BB; Naik S; Westover JB; Brown ER; Gantla VR; Fetsko A; Dagley AL; Blotter DJ; Anderson N; McCormack K; Henkel G
Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.
Shao J; Liu X; Ly H; Liang Y
J Virol; 2016 Nov; 90(22):10390-10397. PubMed ID: 27630230
[TBL] [Abstract][Full Text] [Related]
7. Current drug discovery strategies against arenavirus infections.
Pasquato A; Burri DJ; Kunz S
Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1297-309. PubMed ID: 23241187
[TBL] [Abstract][Full Text] [Related]
8. Identification of a clinical compound losmapimod that blocks Lassa virus entry.
Zhang X; Yan F; Tang K; Chen Q; Guo J; Zhu W; He S; Banadyga L; Qiu X; Guo Y
Antiviral Res; 2019 Jul; 167():68-77. PubMed ID: 30953674
[TBL] [Abstract][Full Text] [Related]
9. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
Zhang X; Tang K; Guo Y
Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348
[TBL] [Abstract][Full Text] [Related]
10. A potent Lassa virus antiviral targets an arenavirus virulence determinant.
Madu IG; Files M; Gharaibeh DN; Moore AL; Jung KH; Gowen BB; Dai D; Jones KF; Tyavanagimatt SR; Burgeson JR; Korth MJ; Bedard KM; Iadonato SP; Amberg SM
PLoS Pathog; 2018 Dec; 14(12):e1007439. PubMed ID: 30576397
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches in anti-arenaviral drug development.
Lee AM; Pasquato A; Kunz S
Virology; 2011 Mar; 411(2):163-9. PubMed ID: 21183197
[TBL] [Abstract][Full Text] [Related]
12. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.
Urata S; Yun N; Pasquato A; Paessler S; Kunz S; de la Torre JC
J Virol; 2011 Jan; 85(2):795-803. PubMed ID: 21068251
[TBL] [Abstract][Full Text] [Related]
14. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
Carnec X; Mateo M; Page A; Reynard S; Hortion J; Picard C; Yekwa E; Barrot L; Barron S; Vallve A; Raoul H; Carbonnelle C; Ferron F; Baize S
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593043
[TBL] [Abstract][Full Text] [Related]
15. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
16. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.
Thomas CJ; Casquilho-Gray HE; York J; DeCamp DL; Dai D; Petrilli EB; Boger DL; Slayden RA; Amberg SM; Sprang SR; Nunberg JH
J Biol Chem; 2011 Feb; 286(8):6192-200. PubMed ID: 21159779
[TBL] [Abstract][Full Text] [Related]
17. Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever.
Tang K; He S; Zhang X; Guo J; Chen Q; Yan F; Banadyga L; Zhu W; Qiu X; Guo Y
Antiviral Res; 2018 Dec; 160():87-93. PubMed ID: 30339847
[TBL] [Abstract][Full Text] [Related]
18. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
19. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
[TBL] [Abstract][Full Text] [Related]
20. The curious case of arenavirus entry, and its inhibition.
Nunberg JH; York J
Viruses; 2012 Jan; 4(1):83-101. PubMed ID: 22355453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
